Financials Xebio Holdings Co., Ltd.

Equities

8281

JP3428800001

Other Specialty Retailers

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
1,005 JPY +0.10% Intraday chart for Xebio Holdings Co., Ltd. +0.30% +5.13%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 94,226 53,894 39,437 41,382 41,868 46,377
Enterprise Value (EV) 1 80,193 38,338 31,685 12,491 17,158 26,121
P/E ratio 22.2 x 28.8 x 97 x 101 x 11 x 8.63 x
Yield 1.66% 2.87% 3.64% 3.21% 3.17% 2.86%
Capitalization / Revenue 0.4 x 0.23 x 0.18 x 0.2 x 0.19 x 0.19 x
EV / Revenue 0.34 x 0.17 x 0.14 x 0.06 x 0.08 x 0.11 x
EV / EBITDA 5.03 x 3.73 x 3.27 x 1.73 x 1.86 x 2.11 x
EV / FCF -12.4 x 5.63 x -5.31 x 0.65 x -4.79 x -49.4 x
FCF Yield -8.1% 17.8% -18.8% 153% -20.9% -2.03%
Price to Book 0.79 x 0.46 x 0.34 x 0.36 x 0.35 x 0.38 x
Nbr of stocks (in thousands) 44,699 44,212 44,212 44,211 44,211 44,211
Reference price 2 2,108 1,219 892.0 936.0 947.0 1,049
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 234,595 231,629 225,312 202,438 223,282 239,293
EBITDA 1 15,958 10,279 9,684 7,224 9,247 12,395
EBIT 1 10,692 5,746 5,233 2,765 5,000 8,328
Operating Margin 4.56% 2.48% 2.32% 1.37% 2.24% 3.48%
Earnings before Tax (EBT) 1 8,858 4,349 3,185 3,094 6,214 8,834
Net income 1 4,249 1,884 408 412 3,836 5,397
Net margin 1.81% 0.81% 0.18% 0.2% 1.72% 2.26%
EPS 2 94.79 42.32 9.200 9.290 86.44 121.6
Free Cash Flow 1 -6,492 6,810 -5,962 19,161 -3,582 -529
FCF margin -2.77% 2.94% -2.65% 9.46% -1.6% -0.22%
FCF Conversion (EBITDA) - 66.25% - 265.24% - -
FCF Conversion (Net income) - 361.45% - 4,650.64% - -
Dividend per Share 2 35.00 35.00 32.50 30.00 30.00 30.00
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 117,505 90,886 107,146 59,899 61,463 118,028 62,336 62,266 120,052 62,094
EBITDA - - - - - - - - - -
EBIT 1 4,126 213 2,102 3,367 4,180 4,041 3,418 2,624 2,968 1,691
Operating Margin 3.51% 0.23% 1.96% 5.62% 6.8% 3.42% 5.48% 4.21% 2.47% 2.72%
Earnings before Tax (EBT) 1 3,466 622 3,253 3,908 4,958 5,178 3,149 3,155 3,662 1,748
Net income 1 1,469 136 1,612 2,984 3,177 3,146 2,074 1,987 2,021 1,225
Net margin 1.25% 0.15% 1.5% 4.98% 5.17% 2.67% 3.33% 3.19% 1.68% 1.97%
EPS 2 33.24 3.080 36.48 67.49 71.87 71.16 46.91 44.95 45.72 27.70
Dividend per Share 17.50 15.00 15.00 - - 15.00 - - 15.00 -
Announcement Date 11/8/19 11/6/20 11/12/21 2/10/22 8/12/22 11/11/22 2/10/23 8/10/23 11/10/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 14,033 15,556 7,752 28,891 24,710 20,256
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -6,492 6,810 -5,962 19,161 -3,582 -529
ROE (net income / shareholders' equity) 3.6% 1.59% 0.36% 0.35% 3.28% 4.64%
ROA (Net income/ Total Assets) 3.55% 1.93% 1.78% 0.89% 1.5% 2.48%
Assets 1 119,818 97,627 22,890 46,538 255,206 217,551
Book Value Per Share 2 2,676 2,679 2,651 2,631 2,684 2,768
Cash Flow per Share 2 370.0 415.0 283.0 1,003 902.0 744.0
Capex 1 1,836 3,031 4,524 2,396 3,521 3,357
Capex / Sales 0.78% 1.31% 2.01% 1.18% 1.58% 1.4%
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 8281 Stock
  4. Financials Xebio Holdings Co., Ltd.